Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia
Not available.
Saved in:
Main Authors: | Yixiao Mo, Qi Zhang, Miao Wang, Jihui Chen, Wenting Hu, Changcheng Chen, Yanjing Tang, Zhuo Wang, Jingjing Wang, Xiaoxiao Chen, Shuhong Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2025-01-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/11905 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteoporosis in Acute Lymphoblastic Leukemia
by: Lestry Fibriani, et al.
Published: (2019-09-01) -
Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
by: Andrew D. Hughes, et al.
Published: (2025-01-01) -
The Determination of Partition Coefficient of 6-Mercaptopurine Derivatives by Thin Layer Chromatography
by: Andrzej Czyrski, et al.
Published: (2013-01-01) -
In vivo monitoring of leukemia-niche interactions in a zebrafish xenograft model.
by: Anja Arner, et al.
Published: (2024-01-01) -
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01)